School of Medicine
Showing 61-70 of 282 Results
-
Rouzbeh Fateh, MD
Clinical Assistant Professor, Neurology & Neurological Sciences
BioDr. Fateh is a fellowship-trained neurologist, specializing in neuromuscular disorders. He is an assistant professor with the Stanford School of Medicine Department of Neurology. His background includes extensive work in neurology, mental health, and neurodevelopmental disabilities.
His practice focuses on providing comprehensive care for complex neurological and neuromuscular diseases. His expertise includes neuropathies, myopathies, and other brain and nerve-related disorders. He is board-certified in neurology, clinical neurophysiology, and electrodiagnostic medicine.
Dr. Fateh was involved in research related to neurodevelopmental disabilities and multiple sclerosis. His work has been published in international journals such as Swiss Medical Weekly and The World Journal of Biological Psychiatry.
He has also given numerous presentations in different meetings including annual meeting of the American Academy of Neurology.
Additional languages spoken: Farsi, Turkish (Azeri dialect) -
Margaret S. Ferris, MD
Clinical Assistant Professor, Neurology & Neurological Sciences
BioDr. Ferris is a fellowship-trained neurologist and Clinical Assistant Professor in the Department of Neurology, Division of Movement Disorders.
She diagnoses and treats a breath of movement disorders such as Parkinson’s disease and essential tremor. She recognizes the broad effects of these conditions on daily living and aims to develop personalized, comprehensive treatment plans that optimize health and quality of life.
Dr. Ferris research interests focus on access to interventional therapies for movement disorders. She has participated in investigations sponsored by the National Institutes of to evaluate advanced treatments for complications of Parkinson’s disease.
She has co-authored articles in publications such as Nature, The Neurohospitalist, and BioMed Central (BMC) Genomics. She has presented her insights about innovations in the understanding, detection, and management of movement disorders at conferences including, the Society for Neuroscience Annual Meeting, Pan American Parkinson’s Disease and Movement Disorders Congress.
She is a member of the American Academy of Neurology and the Movement Disorder Society. -
Anna Finley Caulfield, MD
Clinical Professor, Neurology & Neurological Sciences
Current Research and Scholarly InterestsDr. Finley joined the Stanford Stroke Center in 2004 from Beth Israel Deaconess Medical Center in Boston. She cares for acute stroke patients and other neurologically critical ill patients in the intensive care unit. Currently, her research interests include hypothermia after cardiac arrest and comparing health care provider's predications of future neurological function in neurologically critical ill patients to their 6-month outcome.
-
Robert Fisher, MD, PhD
The Maslah Saul, MD, Professor and Professor, by courtesy, of Neurosurgery
Current Research and Scholarly InterestsDr. Fisher is interested in clincal, laboratory and translational aspects of epilepsy research. Prior work has included: electrical deep brain stimulation for epilepsy, studied in laboratory models and clinical trials; drug delivery to a seizure focus; mechanisms of absence epilepsy studied with in vitro slices of brain thalamus; hyperthermic seizures; diagnosis and treatment of non-epileptic seizures, the post-ictal state; driving and epilepsy; new antiepileptic drugs; surgery for epilepsy.
-
Andrea Fuentes
Clinical Assistant Professor, Neurology & Neurological Sciences
BioDr. Fuentes is a board-certified neurologist with the Movement Disorders Center at Stanford Health Care. She is also a clinical assistant professor in the Department of Neurology and Neurological Sciences. Dr. Fuentes completed a movement disorders fellowship at the University of California, San Francisco.
She provides comprehensive care for patients with different types of movement disorders, including Parkinson’s disease (PD), atypical parkinsonian disorders, essential tremor, ataxia, dystonia, and chorea. As part of her clinical practice, she performs deep brain stimulation (DBS) evaluation and programming and botulinum toxin injections.
Her research efforts include several clinical trials assessing treatments for movement disorders. She has been a sub-investigator on multiple trials evaluating drug candidates for the treatment of PD and ataxia. She has presented her work at national and international meetings, including those for the International Parkinson and Movement Disorder Society and the American College of Physicians.
Dr. Fuentes is a member of the American Academy of Neurology and the International Parkinson and Movement Disorder Society. -
Kristin Galetta, MD
Clinical Assistant Professor, Neurology & Neurological Sciences
BioDr. Galetta is a board-certified neurologist within the Neurohospitalist and Neuroimmunology divisions. She completed a multiple sclerosis (MS) fellowship at Brigham and Women’s Hospital.
She has extensive experience diagnosing and treating patients with autoimmune neurologic conditions including multiple sclerosis, optic neuritis, autoimmune encephalitis and transverse myelitis. Her research interests are focused on understanding best treatment strategies for patients with multiple sclerosis and more rare autoimmune neurologic conditions. She also has an interest in medical education improvement.
She has published in numerous peer-reviewed journals, including the Journal of Neurological Sciences and Multiple Sclerosis and Related Disorders. She is a peer reviewer for multiple prestigious journals, including Neurology and Frontiers in Neurology. -
Paul George, MD, PhD
Associate Professor of Neurology (Adult Neurology) and, by courtesy, of Neurosurgery
Current Research and Scholarly InterestsCONDUCTIVE POLYMER SCAFFOLDS FOR STEM CELL-ENHANCED STROKE RECOVERY:
We focus on developing conductive polymers for stem cell applications. We have created a microfabricated, polymeric system that can continuously interact with its biological environment. This interactive polymer platform allows modifications of the recovery environment to determine essential repair mechanisms. Recent work studies the effect of electrical stimulation on neural stem cells seeded on the conductive scaffold and the pathways by which it enhances stroke recovery Further understanding the combined effect of electrical stimulation and stem cells in augmenting neural repair for clinical translational is a major focus of this research going forward.
BIOPOLYMER SYSTEMS FOR NEURAL RECOVERY AND STEM CELL MODULATION:
The George lab develops biomaterials to improve neural recovery in the peripheral and central nervous systems. By controlled release of drugs and molecules through biomaterials we can study the temporal effect of these neurotrophic factors on neural recovery and engineer drug delivery systems to enhance regenerative effects. By identifying the critical mechanisms for stroke and neural recovery, we are able to develop polymeric technologies for clinical translation in nerve regeneration and stroke recovery. Recent work utilizing these novel conductive polymers to differentiate stem cells for therapeutic and drug discovery applications.
APPLYING ENGINEERING TECHNIQUES TO DETERMINE BIOMARKERS FOR STROKE DIAGNOSTICS:
The ability to create diagnostic assays and techniques enables us to understand biological systems more completely and improve clinical management. Previous work utilized mass spectroscopy proteomics to find a simple serum biomarker for TIAs (a warning sign of stroke). Our study discovered a novel candidate marker, platelet basic protein. Current studies are underway to identify further candidate biomarkers using transcriptome analysis. More accurate diagnosis will allow for aggressive therapies to prevent subsequent strokes.
